NCT03781258View on ClinicalTrials.gov

Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)

NAUnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 23, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Heart FailureCardiovascular Diseases

Interventions

DRUG

Warfarin

Anti-thrombotic monotherapy (ASA)-Warfarin withdrawal.

Trial Locations (1)

14021

Institute for Clinical and Experimental Medicine, Prague

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Institute for Clinical and Experimental Medicine

OTHER_GOV

NCT03781258 - Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) | Biotech Hunter | Biotech Hunter